Biotechnology Companies By Profit Margin

Profit Margin
Profit MarginEfficiencyMarket RiskExp Return
1INBX Inhibrx
1.02 K
(0.06)
 3.07 
(0.18)
2NWBO Northwest Biotherapeutics
52.11
(0.01)
 4.03 
(0.04)
3ROIV Roivant Sciences
37.25
(0.02)
 2.05 
(0.05)
4XFOR X4 Pharmaceuticals
31.32
 0.06 
 13.43 
 0.81 
5AGIO Agios Pharm
20.51
(0.09)
 4.74 
(0.44)
6ADXN Addex Therapeutics
5.0
(0.04)
 5.76 
(0.26)
7GLPG Galapagos NV ADR
0.79
(0.17)
 2.44 
(0.41)
8PTGX Protagonist Therapeutics
0.53
(0.12)
 2.89 
(0.33)
9XOMAP XOMA Corp
0.46
(0.02)
 0.70 
(0.01)
10XOMAO XOMA Corporation
0.46
 0.05 
 0.31 
 0.02 
11HALO Halozyme Therapeutics
0.41
 0.05 
 3.57 
 0.17 
12UTHR United Therapeutics
0.4
 0.00 
 1.86 
 0.00 
13REGN Regeneron Pharmaceuticals
0.34
(0.27)
 1.96 
(0.53)
14CPRX Catalyst Pharmaceuticals
0.31
 0.05 
 3.04 
 0.17 
15LGND Ligand Pharmaceuticals Incorporated
0.3
 0.04 
 3.13 
 0.11 
16GNFT Genfit
0.28
(0.31)
 2.76 
(0.85)
17MEIP MEI Pharma
0.27
 0.02 
 2.63 
 0.05 
18MDXG MiMedx Group
0.26
 0.20 
 4.33 
 0.86 
19TRDA Entrada Therapeutics
0.26
(0.13)
 3.39 
(0.45)
20GMAB Genmab AS
0.24
(0.05)
 1.83 
(0.10)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs. In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.